Arun Nagarajan, MD, of Cleveland Clinic Florida, discusses new research published in JAMA on biomarker testing disparities in metastatic colorectal cancer.
[ad_2]
Source link
Disparities in Biomarker Testing for Metastatic Colorectal Cancer
You May Also Like
More From Author
Study shows shift in GLP-1 drug use for obesity, not diabetes
